Benzinga's Top Upgrades, Downgrades For October 2, 2020

Loading...
Loading...

Upgrades

  • According to Evercore ISI Group, the prior rating for Splunk Inc SPLK was changed from In-Line to Outperform. Splunk earned $0.33 in the second quarter, compared to $0.67 in the year-ago quarter. The current stock performance of Splunk shows a 52-week-high of $225.89 and a 52-week-low of $93.92. Moreover, at the end of the last trading period, the closing price was at $192.56.
  • According to B of A Securities, the prior rating for Nu Skin Enterprises Inc NUS was changed from Underperform to Neutral. Nu Skin Enterprises earned $0.81 in the second quarter, compared to $0.83 in the year-ago quarter. The stock has a 52-week-high of $53.63 and a 52-week-low of $12.30. At the end of the last trading period, Nu Skin Enterprises closed at $51.17.
  • According to Truist Securities, the prior rating for Medpace Holdings Inc MEDP was changed from Hold to Buy. For the second quarter, Medpace Hldgs had an EPS of $0.64, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $144.49 and a 52-week-low of $58.72. At the end of the last trading period, Medpace Hldgs closed at $114.16.
  • Susquehanna upgraded the previous rating for JB Hunt Transport Services Inc JBHT from Neutral to Positive. JB Hunt Transport Servs earned $1.14 in the second quarter, compared to $1.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $144.34 and a 52-week-low of $75.29. JB Hunt Transport Servs closed at $125.21 at the end of the last trading period.
  • For Immunogen Inc IMGN, Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Immunogen showed an EPS of $0.14, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.07 and a 52-week-low of $1.95. Immunogen closed at $3.70 at the end of the last trading period.
  • For American Eagle Outfitters Inc AEO, B of A Securities upgraded the previous rating of Underperform to the current rating Neutral. In the second quarter, American Eagle Outfitters showed an EPS of $0.03, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.82 and a 52-week-low of $6.54. American Eagle Outfitters closed at $14.91 at the end of the last trading period.
  • For Carvana Co CVNA, Morgan Stanley upgraded the previous rating of Underweight to the current rating Equal-Weight. In the second quarter, Carvana showed an EPS of $0.62, compared to $0.40 from the year-ago quarter. The current stock performance of Carvana shows a 52-week-high of $242.15 and a 52-week-low of $22.16. Moreover, at the end of the last trading period, the closing price was at $237.67.
  • For Donaldson Co Inc DCI, Baird upgraded the previous rating of Neutral to the current rating Outperform. In the fourth quarter, Donaldson showed an EPS of $0.50, compared to $0.61 from the year-ago quarter. At the moment, the stock has a 52-week-high of $58.32 and a 52-week-low of $31.08. Donaldson closed at $46.92 at the end of the last trading period.
  • For Six Flags Entertainment Corp SIX, Goldman Sachs upgraded the previous rating of Sell to the current rating Neutral. Six Flags Entertainment earned $1.62 in the second quarter, compared to $0.99 in the year-ago quarter. The current stock performance of Six Flags Entertainment shows a 52-week-high of $53.00 and a 52-week-low of $8.75. Moreover, at the end of the last trading period, the closing price was at $19.96.
  • For Workday Inc WDAY, Stifel upgraded the previous rating of Hold to the current rating Buy. For the second quarter, Workday had an EPS of $0.84, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $248.75 and a 52-week-low of $107.75. At the end of the last trading period, Workday closed at $220.52.
  • According to DZ Bank, the prior rating for Walmart Inc WMT was changed from Hold to Buy. For the second quarter, Walmart had an EPS of $1.56, compared to year-ago quarter EPS of $1.27. The stock has a 52-week-high of $151.33 and a 52-week-low of $102.00. At the end of the last trading period, Walmart closed at $143.07.
  • According to Evercore ISI Group, the prior rating for CSX Corp CSX was changed from In-Line to Outperform. In the second quarter, CSX showed an EPS of $0.65, compared to $1.08 from the year-ago quarter. The current stock performance of CSX shows a 52-week-high of $81.40 and a 52-week-low of $46.81. Moreover, at the end of the last trading period, the closing price was at $76.86.
  • Raymond James upgraded the previous rating for Targa Resources Corp TRGP from Outperform to Strong Buy. In the second quarter, Targa Resources showed an EPS of $0.21, compared to $0.18 from the year-ago quarter. The stock has a 52-week-high of $42.12 and a 52-week-low of $3.66. At the end of the last trading period, Targa Resources closed at $13.58.

 

Downgrades

  • Susquehanna downgraded the previous rating for Landstar System Inc LSTR from Positive to Neutral. For the second quarter, Landstar System had an EPS of $0.68, compared to year-ago quarter EPS of $1.53. The stock has a 52-week-high of $139.99 and a 52-week-low of $85.30. At the end of the last trading period, Landstar System closed at $125.18.
  • According to HC Wainwright & Co., the prior rating for AMAG Pharmaceuticals Inc AMAG was changed from Buy to Neutral. For the second quarter, AMAG Pharmaceuticals had an EPS of $0.57, compared to year-ago quarter EPS of $1.14. The stock has a 52-week-high of $13.80 and a 52-week-low of $4.41. At the end of the last trading period, AMAG Pharmaceuticals closed at $13.65.
  • Wells Fargo downgraded the previous rating for DexCom Inc DXCM from Equal-Weight to Underweight. DexCom earned $0.79 in the second quarter, compared to $0.08 in the year-ago quarter. The current stock performance of DexCom shows a 52-week-high of $456.23 and a 52-week-low of $145.23. Moreover, at the end of the last trading period, the closing price was at $413.84.
  • For General Dynamics Corp GD, Baird downgraded the previous rating of Outperform to the current rating Neutral. For the second quarter, General Dynamics had an EPS of $2.18, compared to year-ago quarter EPS of $2.77. At the moment, the stock has a 52-week-high of $190.08 and a 52-week-low of $100.55. General Dynamics closed at $138.22 at the end of the last trading period.

 

Initiations

  • SVB Leerink initiated coverage on Immunic Inc IMUX with an Outperform rating. The price target for Immunic is set to $45.00. In the second quarter, Immunic showed an EPS of $0.90, compared to $1.52 from the year-ago quarter. The stock has a 52-week-high of $23.39 and a 52-week-low of $4.19. At the end of the last trading period, Immunic closed at $18.87.
  • Benchmark initiated coverage on Fortress Biotech Inc FBIO with a Buy rating. The price target for Fortress Biotech is set to $9.00. Fortress Biotech earned $0.05 in the second quarter, compared to $0.51 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.78 and a 52-week-low of $1.04. Fortress Biotech closed at $4.03 at the end of the last trading period.
  • With a current rating of Equal-Weight, Barclays initiated coverage on Shaw Communications Inc SJR. The price target seems to have been set at $21.00 for Shaw Communications. In the third quarter, Shaw Communications showed an EPS of $0.27, compared to $0.33 from the year-ago quarter. The current stock performance of Shaw Communications shows a 52-week-high of $20.90 and a 52-week-low of $12.20. Moreover, at the end of the last trading period, the closing price was at $18.31.
  • For Rogers Communications Inc RCI, Barclays initiated coverage, by setting the current rating at Equal-Weight. Rogers Communications earned $0.43 in the second quarter, compared to $0.88 in the year-ago quarter. The stock has a 52-week-high of $51.29 and a 52-week-low of $32.20. At the end of the last trading period, Rogers Communications closed at $39.80.
  • Bernstein initiated coverage on Humana Inc HUM with a Market Perform rating. The price target for Humana is set to $459.00. Humana earned $12.56 in the second quarter, compared to $6.05 in the year-ago quarter. The stock has a 52-week-high of $431.12 and a 52-week-low of $208.25. At the end of the last trading period, Humana closed at $415.07.
  • Raymond James initiated coverage on GoHealth Inc GOCO with an Outperform rating. The price target for GoHealth is set to $18.00. GoHealth earned $0.07 in the second quarter. The current stock performance of GoHealth shows a 52-week-high of $20.47 and a 52-week-low of $12.22. Moreover, at the end of the last trading period, the closing price was at $13.72.
  • With a current rating of Outperform, SVB Leerink initiated coverage on Xenon Pharmaceuticals Inc XENE. The price target seems to have been set at $22.00 for Xenon Pharmaceuticals. For the second quarter, Xenon Pharmaceuticals had an EPS of $0.00, compared to year-ago quarter EPS of $0.37. The current stock performance of Xenon Pharmaceuticals shows a 52-week-high of $18.45 and a 52-week-low of $7.00. Moreover, at the end of the last trading period, the closing price was at $11.19.
  • Stifel initiated coverage on Evofem Biosciences Inc EVFM with a Buy rating. The price target for Evofem Biosciences is set to $5.00. Evofem Biosciences earned $0.39 in the second quarter, compared to $0.95 in the year-ago quarter. The stock has a 52-week-high of $7.50 and a 52-week-low of $1.91. At the end of the last trading period, Evofem Biosciences closed at $2.39.
  • BMO Capital initiated coverage on TechnipFMC PLC FTI with a Market Perform rating. The price target for TechnipFMC is set to $7.50. TechnipFMC earned $0.09 in the second quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.14 and a 52-week-low of $4.49. TechnipFMC closed at $6.27 at the end of the last trading period.
  • BMO Capital initiated coverage on Halliburton Co HAL with a Market Perform rating. The price target for Halliburton is set to $14.00. For the second quarter, Halliburton had an EPS of $0.05, compared to year-ago quarter EPS of $0.35. At the moment, the stock has a 52-week-high of $25.47 and a 52-week-low of $4.25. Halliburton closed at $11.17 at the end of the last trading period.
  • Loop Capital initiated coverage on Papa John's International Inc PZZA with a Buy rating. The price target for Papa John's International is set to $110.00. Papa John's International earned $0.48 in the second quarter, compared to $0.28 in the year-ago quarter. The current stock performance of Papa John's International shows a 52-week-high of $102.25 and a 52-week-low of $28.55. Moreover, at the end of the last trading period, the closing price was at $83.33.
  • With a current rating of Buy, Loop Capital initiated coverage on Shake Shack Inc SHAK. The price target seems to have been set at $78.00 for Shake Shack. Shake Shack earned $0.45 in the second quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $97.93 and a 52-week-low of $30.01. Shake Shack closed at $64.92 at the end of the last trading period.
  • With a current rating of Outperform, BMO Capital initiated coverage on Schlumberger Ltd SLB. The price target seems to have been set at $21.00 for Schlumberger. Schlumberger earned $0.05 in the second quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $41.14 and a 52-week-low of $11.87. Schlumberger closed at $15.02 at the end of the last trading period.
  • With a current rating of Market Perform, Bernstein initiated coverage on Snowflake Inc SNOW. The price target seems to have been set at $270.00 for Snowflake. At the moment, the stock has a 52-week-high of $278.26 and a 52-week-low of $208.55. Snowflake closed at $243.35 at the end of the last trading period.
  • Jefferies initiated coverage on Unum Therapeutics Inc UMRX with a Buy rating. The price target for Unum Therapeutics is set to $4.00. Unum Therapeutics earned $0.24 in the second quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.72 and a 52-week-low of $0.29. Unum Therapeutics closed at $2.26 at the end of the last trading period.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Penny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsIndustrialsInitiationstop upgradesTrucking
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...